glp-1 and muscle growth matters: the effects of medically induced weight loss on skeletal muscle GLP-1 Muscle Loss: The Fear

The link between the weight loss drug Wegovy and gastroparesis side effects was not adequately disclosed by Novo Nordisk, even though the drug maker was aware of wide spread reports involving stomach problems from Ozempic, which was introduced several years earlier for treatment of diabetes and contains the same active ingredient, semaglutide

GLP-1 patches may be trending, but theyre not a medically recognised treatment

Symptoms will usually resolve once blood sugar levels normalize

Clinicians should exercise caution until larger, carefully planned prospective trials elucidate these correlations, particularly when administering GLP-1 RAs for prolonged periods of time in individuals that are already at risk for colorectal cancers

Two The most important distinction between semaglutide and tirzepatide comes down to how they work in the body

Contemporary classification of glucagon-like peptide 1 receptor agonists (GLP1RAs)